Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KD5P
|
|||
| Former ID |
DNCL003098
|
|||
| Drug Name |
Nefiracetam
|
|||
| Synonyms |
Motiva (TN)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Company |
Neuren Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H18N2O2
|
|||
| Canonical SMILES |
CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
|
|||
| InChI |
1S/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17)
|
|||
| InChIKey |
NGHTXZCKLWZPGK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 77191-36-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
6562736, 8194462, 12013546, 14823324, 43127538, 48414094, 49857518, 50156955, 57318037, 58107079, 76715561, 85174243, 90340767, 92714424, 98528231, 103568038, 104253441, 104349792, 117416042, 117600287, 118842184, 121361300, 124757565, 124896718, 125164369, 125357544, 126624140, 126655413, 126684412, 128698296, 131326123, 135027345, 135698040, 136348705, 136367560, 137009454, 142291705, 144076160, 144207070, 144209114, 144213342, 152034502, 162037749, 162178303, 163136677, 163412983, 163564401, 164175273, 164814648, 170466286
|
|||
| ChEBI ID |
CHEBI:135004
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00001933) Nefiracetam in the Treatment of Alzheimer's Disease. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.